Medical Therapy and Scleral Windows for Uveal Effusion Syndrome: A Case Series and Literature Review

Henry H Li; Kaitlyn C Hunter; Andrew C Thomson; Allan A Hunter

doi:10.1007/s40123-022-00601-z

Medical Therapy and Scleral Windows for Uveal Effusion Syndrome: A Case Series and Literature Review

Ophthalmol Ther. 2023 Feb;12(1):35-53. doi: 10.1007/s40123-022-00601-z. Epub 2022 Nov 21.

Authors

Henry H Li^{1

2}, Kaitlyn C Hunter³, Andrew C Thomson^{4

3}, Allan A Hunter³

Affiliations

¹ Case Western Reserve University School of Medicine, Cleveland, OH, USA. Hhl19@case.edu.
² Oregon Eye Consultants, LLC, 1550 Oak Street, Suite 7, Eugene, OR, 97401, USA. Hhl19@case.edu.
³ Oregon Eye Consultants, LLC, 1550 Oak Street, Suite 7, Eugene, OR, 97401, USA.
⁴ McGovern Medical School, The University of Texas Health Science Center, Houston, TX, USA.

Abstract

Introduction: Uveal effusion syndrome (UES) is a rare ocular disease causing idiopathic uveal effusion, often with associated ciliochoroidal and retinal detachment. UES diagnosis is challenging because of overlapping features with other ocular inflammatory, neoplastic, iatrogenic, and drug-induced causes of uveal effusion. While several successful surgical treatments have been described, such as full-thickness or partial-thickness sclerectomy, medical therapies may also have a therapeutic role.

Objective: To provide an updated review of the published literature on the course of the disease, medical and surgical management strategies, as well as newer treatment modalities.

Keywords: Choroidal effusion; Literature review; Scleral windows; Uveal effusion syndrome.

Publication types

Review